Study on Gilteritinib, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia | Clinical Trial

Study on Gilteritinib, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia | Clinical Trial | Right2Hope